Clinical trial shows newborns with spinal muscular atrophy (SMA) can start treatment at birth
August 13, 2025
August 13, 2025
MEMPHIS, Tennessee, Aug. 13 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
Clinical trial shows newborns with spinal muscular atrophy (SMA) can start treatment at birth
*
Spinal muscular atrophy (SMA) is a rare genetic condition that causes progressive muscle weakness, which, when untreated, prevents infants with the most severe form from gaining motor development -- never gaining . . .
* * *
Clinical trial shows newborns with spinal muscular atrophy (SMA) can start treatment at birth
*
Spinal muscular atrophy (SMA) is a rare genetic condition that causes progressive muscle weakness, which, when untreated, prevents infants with the most severe form from gaining motor development -- never gaining . . .